Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 2
2013 1
2014 3
2015 8
2016 13
2017 13
2018 19
2019 12
2020 15
2021 21
2022 22
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties.
Khalili Ghomi M, Noori M, Mirahmad M, Iraji A, Sadr AS, Dastyafteh N, Asili P, Gholami M, Javanshir S, Lotfi M, Mojtabavi S, Faramarzi MA, Asadi M, Nasli-Esfahani E, Palimi M, Larijani B, Meshkatalsadat MH, Mahdavi M. Khalili Ghomi M, et al. Among authors: nasli esfahani e. Eur J Med Chem. 2024 Apr 5;269:116332. doi: 10.1016/j.ejmech.2024.116332. Epub 2024 Mar 16. Eur J Med Chem. 2024. PMID: 38508120
Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
Farzaneh E, Mohammadi M, Raymand P, Noori M, Golestani S, Ranjbar S, Ghasemi Y, Mohammadi-Khanaposhtani M, Asadi M, Nasli Esfahani E, Rastegar H, Larijani B, Mahdavi M, Taslimi P. Farzaneh E, et al. Among authors: nasli esfahani e. Bioorg Chem. 2024 Apr;145:107207. doi: 10.1016/j.bioorg.2024.107207. Epub 2024 Feb 15. Bioorg Chem. 2024. PMID: 38402795
Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease study 2019.
Namazi N, Moghaddam SS, Esmaeili S, Peimani M, Tehrani YS, Bandarian F, Shobeiri P, Nasli-Esfahani E, Malekpour MR, Rezaei N, Rezaei N, Arjmand B, Larijani B, Farzadfar F. Namazi N, et al. Among authors: nasli esfahani e. BMC Public Health. 2024 Jan 5;24(1):98. doi: 10.1186/s12889-023-16540-8. BMC Public Health. 2024. PMID: 38183083 Free PMC article. Review.
Correction to: The effect of personalized intelligent digital systems for self‑care training on type II diabetes: a systematic review and meta‑analysis of clinical trials.
Tanhapour M, Peimani M, Rostam Niakan Kalhori S, Nasli Esfahani E, Shakibian H, Mohammadzadeh N, Qorbani M. Tanhapour M, et al. Among authors: nasli esfahani e. Acta Diabetol. 2023 Dec;60(12):1633. doi: 10.1007/s00592-023-02179-9. Acta Diabetol. 2023. PMID: 37710134 No abstract available.
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides.
Safapoor S, Halimi M, Ghomi MK, Noori M, Dastyafteh N, Javanshir S, Hosseini S, Mojtabavi S, Faramarzi MA, Nasli-Esfahani E, Larijani B, Fakhrioliaei A, Dekamin MG, Mohammadi-Khanaposhtani M, Mahdavi M. Safapoor S, et al. Among authors: nasli esfahani e. RSC Adv. 2023 Jun 26;13(28):19243-19256. doi: 10.1039/d3ra01790g. eCollection 2023 Jun 22. RSC Adv. 2023. PMID: 37377867 Free PMC article.
Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents.
Emadi M, Halimi M, Moazzam A, Hosseini S, Mojtabavi S, Faramarzi MA, Ghadimi R, Moghadamnia AA, Nasli-Esfahani E, Mohammadi-Khanaposhtani M, Mahdavi M. Emadi M, et al. Among authors: nasli esfahani e. Sci Rep. 2023 Jun 20;13(1):10030. doi: 10.1038/s41598-023-36890-y. Sci Rep. 2023. PMID: 37340010 Free PMC article.
Management goal achievements of diabetes care in Iran: study profile and main findings of DiaCare survey.
Shafiee G, Gharibzadeh S, Panahi N, Razi F, Arzaghi SM, Haghpanah V, Ostovar A, Raeisi A, Mahdavi-Hezareh A, Larijani B, Esfahani EN, Heshmat R. Shafiee G, et al. Among authors: esfahani en. J Diabetes Metab Disord. 2022 Nov 2;22(1):355-366. doi: 10.1007/s40200-022-01149-2. eCollection 2023 Jun. J Diabetes Metab Disord. 2022. PMID: 37255823 Free PMC article.
131 results